作者
Laith J Abu-Raddad, Hiam Chemaitelly, Adeel A Butt
发表日期
2021/7/8
期刊
New England Journal of Medicine
卷号
385
期号
2
页码范围
187-189
出版商
Massachusetts Medical Society
简介
Efficacy of the BNT162b2 mRNA Vaccine in Qatar
As of March 31, 2021, more than 265,000 people in Qatar had received both doses of the BNT162b2 vaccine. Viral sequencing indicated that 50.0% of infections from February 23 to March 18 were caused by B.1.351 and 44.5% by B.1.1.7. Vaccine effectiveness was 89.5% against the B.1.1.7 variant and 75.0% against the B.1.351 variant. Effectiveness against severe, critical, or fatal disease was 97.4%.
引用总数
学术搜索中的文章
LJ Abu-Raddad, H Chemaitelly, AA Butt - New England Journal of Medicine, 2021